E-ISSN: 2814 – 1822; P-ISSN: 2616 – 0668
ORIGINAL RESEARCH ARTICLE
Shitu Teslim .
Department of Microbiology, University of Ilorin, Ilorin, Nigeria
Antimicrobial resistance of Salmonella and Shigella remains a significant public health concern globally, particularly in developing nations like Nigeria. This study aimed to assess the prevalence and antibiotic susceptibility of Salmonella and Shigella strains in diarrheal cases linked to the consumption of contaminated water from a shared source in Jimeta-Yola metropolis, Adamawa State. A total of 78 stool samples were obtained for culture using standard methods, with 37 (47.4%) displaying growth of Salmonella and Shigella strains. Through appropriate biochemical tests, the isolates were identified as Salmonella Typhi (35.1%), Salmonella Typhimurium (8.1%), and Shigella species (56.8%), with Shigella exhibiting the highest occurrence. Antibiotic susceptibility testing was conducted using ten selected antibiotics: Ampicillin, Ceftriaxone, Cephalexin, Chloramphenicol, Ciprofloxacin, Co-trimoxazole, Gentamicin, Nitrofurantoin, Ofloxacin, and Tetracycline. Salmonella Typhi isolates showed 76.9% susceptibility to Gentamicin and Ceftriaxone, 61.5% susceptibility to Ofloxacin, 53.8% susceptibility to Chloramphenicol, Ciprofloxacin, Nitrofurantoin, 38.5% susceptibility to Tetracycline, 30.8% susceptibility to Co-trimoxazole, and 23.1% susceptibility to Cephalexin. Shigella species exhibited 95.2% susceptibility to Ofloxacin, 90.5% susceptibility to Gentamicin, 85.7% susceptibility to Ciprofloxacin, 66.7% susceptibility to Ceftriaxone, 57.1% susceptibility to Chloramphenicol, 52.4% susceptibility to Nitrofurantoin, 33.3% susceptibility to Tetracycline, 28.6% susceptibility to Co-trimoxazole, 19% susceptibility to Cephalexin, and 4.8% susceptibility to Ampicillin. Meanwhile, Salmonella Typhimurium displayed 66.7% susceptibility to Ofloxacin, 100% susceptibility to Gentamicin, Chloramphenicol, Nitrofurantoin, Ciprofloxacin, and 33.3% susceptibility to Ampicillin, Cephalexin, Tetracycline, Co-trimoxazole, and Ceftriaxone. The study highlights the persistent high prevalence of Salmonella and Shigella infections and the emergence of complete resistance to Ampicillin, Cephalexin, and Co-trimoxazole. However, Gentamicin and Ciprofloxacin are identified as effective treatment options for infections caused by these pathogens. Therefore, ensuring the availability of safe water sources, promoting hygienic practices, treating drinking water at the point of use (POU) such as boiling, and continuous monitoring are crucial in controlling the dissemination of these organisms.
Keywords: Antibiotic resistance, Occurrence, Diarrhea, Pathogens, Contaminated water
One of the highly-rated threats to public health in the 21st century is the incidence of antimicrobial resistance, which has been accelerated in developing countries like Nigeria due to factors such as poverty, laboratory diagnostic challenges, inappropriate use of antibiotics, unrestricted access, and breaches in the quality of drugs (Ovia et al., 2023). The emergence of antibiotic-resistant Salmonella and Shigella poses a significant threat to delivering reliable therapies, which is a major concern for high-, middle-, and low-income countries. Antibiotic resistance refers to the decreased sensitivity or complete insensitivity of microbes to a variety of drugs that are meant to cause cell death or inhibit their growth (Nadeem et al., 2020). Despite intensified efforts by governments at all levels to combat these organisms, their infections remain persistent due to antibiotic resistance. The tremendous therapeutic advantage afforded by antibiotics is being threatened by the emergence of these increasingly resistant strains of microbes. Contamination of drinking water also facilitates the transmission of gastrointestinal diseases such as diarrhea to human populations, which remains a persistent issue in developing countries where the quality of water supplies has been compromised due to unsustainable demographic growth and breaches in the integrity of distribution systems (Agbabiaka et al., 2021).
Salmonella and Shigella cause mild to severe intestinal tract infections. Salmonella can lead to self-limited gastroenteritis or more severe systemic typhoid fever, while Shigella species typically remain in the human intestinal tract, causing diarrhea and bacillary dysentery, often transmitted through the fecal-oral route (WHO, 2003). Diarrhea is characterized by abnormal stool consistency, including watery, bloody, or loose stools occurring more than twice a day (WHO 2017). It ranks among the top three causes of childhood mortality in Sub-Saharan Africa, notably Nigeria, with over one billion cases globally resulting in 3 million deaths annually, predominantly from non-typhoidal Salmonella and Shigella infections, accounting for 99% of the 200 million diarrheal cases and over 650,000 deaths in developing countries, particularly affecting children and young adults (Tesfahun et al., 2016). Legese et al. (2020) also noted severe post-diarrheal complications such as inflammatory bowel diseases, irritable bowel syndrome, arthritis, sepsis, myocarditis, peritonitis, and Reiter’s syndrome in individuals previously infected with Salmonella and Shigella. These infections are widespread in developing nations with inadequate access to clean water, improper waste and sewage disposal, and poor hygienic practices among the population (Abebe et al., 2018). Effective prevention in high morbidity areas heavily relies on proper hygiene practices and sanitation. Additionally, continuous epidemiological surveillance is crucial for combating antimicrobial resistance in Salmonella and Shigella infections, aligning with the UN's Sustainable development goal (SDG) 3 on ensuring good health and well-being. Given the escalating cases of antibiotic resistance in Salmonella and Shigella infections globally, it is imperative to conduct comprehensive studies in this region to assess the prevalence and dominance of these resistant strains. This study aims to determine the occurrence of antibiotic-resistant Salmonella and Shigella species in diarrheal cases associated with the consumption of contaminated water from a shared source in the Jimeta-Yola metropolis of Adamawa state.
The study area was Jimeta-Yola Metropolis, Adamawa State. Stool samples were collected from patients attending the Federal Medical Centre Yola. Jimeta is the commercial city in Adamawa State and is located at the center of the state. The area was selected for the study due to its high population density and the diverse group of people residing in the area.
Stool samples were collected from 78 patients who reported experiencing diarrhea after consuming contaminated water sold within the metropolis. The samples were collected in wide-mouthed sterile plastic containers with screw caps, and a corresponding water sample was appropriately labeled for bacterial culture to identify Salmonella and Shigella species. All samples were securely packed and transported to the microbiology laboratory at Modibbo Adama University of Technology (MAUTECH) Yola in cool boxes for isolation, identification, and antimicrobial susceptibility testing.
For the isolation of bacteria, a loopful of each stool sample was emulsified in normal saline and then inoculated directly onto pre-prepared plates of Deoxycholate Citrate Agar (DCA) and Salmonella-Shigella media. A sterile wire loop was used to make a pool first and then streak in a zigzag fashion while sterilizing the loop at intervals. Additionally, a loopful of the water sample was plated on both Deoxycholate Citrate Agar (DCA) and Salmonella-Shigella media to confirm the source of these organisms. The inoculated plates were incubated at 37°C for 24 hours. Subsequently, the isolated non-lactose fermenting colonies on the plates were screened and confirmed through appropriate biochemical tests (Adekunle et al., 2015).
Salmonella and Shigella species were identified through standard biochemical tests and identification charts for enteric organisms. Salmonella Typhi isolates were additionally confirmed by a slide agglutination test using Salmonella Typhi typing antisera (Cheesebrough, 2006).
The disc diffusion susceptibility method was performed to test the susceptibility of Salmonella and Shigella isolates to antibiotics using standard procedures. Firstly, the inoculum was prepared by introducing a clear discrete colony of the test organism into peptone water and incubated for 6 hours at 37°C. Subsequently, the resultant turbidity of the broth was adjusted to 0.5 McFarland standard of turbidity. A sterile wire loop was then used to spread the suspension of the organism all over the entire surface of Mueller Hinton medium and allowed to absorb for 3 minutes. A single disc containing a specific concentration of each antimicrobial agent was firmly placed onto the inoculated surface with the aid of an applicator stick, and the plates were incubated inverted at 37°C for 24 hours.
After the 24 hours of incubation, we observed the plates for clear zones of inhibition, which were then measured in mm using a straight line rule. The diameter of the zone was read using an interpreting chart for zone sizes, and the findings were recorded as susceptible, intermediate, and resistant (CLSI, 2016). The antibiotics used included Ampicillin 25µg, Tetracycline 25µg, Chloramphenicol 30µg, Co-trimoxazole 25µg, Cephalexin 15µg, Nitrofurantoin 200µg, Ceftriaxone 30µg, Gentamicin 10µg, Ofloxacin 10µg, and Ciprofloxacin 10µg.
Out of the 78 stool samples collected, 37 samples showed the growth of Salmonella and Shigella species. Among these, 21 (56.8%) were identified as Shigella species, 13 (35.1%) as Salmonella enterica Typhi, and 3 (8.1%) as Salmonella enterica Typhimurium, as depicted in Figure 1. In terms of gender distribution, 23 (62.2%) of the patients were males, while 14 (37.8%) were females, as illustrated in Figure 2. The mean age of the patients from whom either Salmonella or Shigella were isolated was 19 years, with an age range of 4 to 63 years, as shown in Figure 3.
The colonial morphology of the Salmonella isolates was smooth, colorless colonies with or without blackening around them, indicating non-lactose fermentation. The Shigella isolates also displayed colorless colonies without blackening, consistent with non-lactose fermentation. Results from the Kligler iron agar (KIA) test showed that Shigella produced a red slope and yellow butt without gas or hydrogen sulfide (H2S) production. On the other hand, Salmonella enterica Typhi exhibited a red slope and yellow butt with a small amount of H2S, while Salmonella enterica Typhimurium displayed a red slope and significant blackening of the entire butt due to high levels of H2S production, as illustrated in Plate 1 and Table 1.
Both Shigella and Salmonella isolates exhibited higher resistance than susceptibility to the tested antibiotics. The most significant resistance was observed for Ampicillin and Cephalexin, with Salmonella Typhi, Salmonella Typhimurium, and Shigella isolates showing 100%, 76.9%, and 95.2% resistance, respectively. In contrast, the highest susceptibility was seen with Ofloxacin and Gentamicin, with Salmonella enterica Typhi, Salmonella enterica Typhimurium, and Shigella isolates displaying 61.5%, 66.7%, and 95.2% susceptibility, respectively, as detailed in Table 2.
The findings of this study indicate the presence of Salmonella and Shigella in the analyzed stool samples. Out of the 78 samples, 37 (47.4%) showed the growth of these pathogens, with Shigella species being more prevalent than Salmonella species. This highlights the continued high prevalence of these pathogens in the metropolis, particularly in waterborne diseases originating from contaminated water sources, as both Salmonella and Shigella were identified in the tested water sample. These results align with previous reports by Abebe et al. (2018) and Dessale et al. (2023) which also noted a high prevalence of these organisms. The study also found that 62.2% of the isolates were from male patients, while 37.8% were from females, suggesting no gender association with Salmonella and Shigella infections. The age range of patients varied from 4 to 63 years, indicating that these infections are not limited to a specific age group. However, the study revealed that children between 0 to 9 years old were most susceptible to these infections, possibly due to unhygienic habits or poor sanitation practices among children.
Antibiotic resistance in Salmonella and Shigella is prevalent in developing countries, largely due to poor hygiene, lack of clean drinking water, and consumption of contaminated foods. Out of the 37 clinical isolates characterized, 33 (89.2%) were found to be multi-drug resistant strains, showing resistance to three or more commonly used antibiotics. This high rate of resistance may stem from the extensive use of these drugs as the primary treatment for infectious diarrhea and typhoid fever, or from issues like self-medication, under-dosage, or overuse of antibiotics. Among the Salmonella enterica Typhi isolates, resistance rates of 100% for Ampicillin, 76.9% for Cephalexin, and 61.5% for Tetracycline were observed. For Salmonella enterica Typhimurium, an overall resistance of 66.7% was noted for Ampicillin, Cephalexin, Tetracycline, Ceftriaxone, and Co-trimoxazole. Regarding Shigella species, an overall resistance of 95.2%, 81%, and 71.4% to Ampicillin, Cephalexin, and Co-trimoxazole, respectively, was identified. The study reveals a general resistance of the isolates to Ampicillin, Cephalexin, Co-trimoxazole, and Tetracycline, consistent with the findings of Diriba et al. (2020) who similarly reported resistance of Salmonella and Shigella to these antibiotics.
Table 1: Biochemical features of the Salmonella and Shigella species isolated
S/No | KIA Medium | Motility test | Citrate test | Isolates | |||
---|---|---|---|---|---|---|---|
Slope | Butt | H2S | Gas | ||||
1 | R | Y | - | - | - | - | Shigella |
2 | R | Y | - | - | - | - | Shigella |
3 | R | Y | + | - | + | - | S. Typhi |
4 | R | Y | - | - | - | - | Shigella |
5 | R | Y | - | - | - | - | Shigella |
6 | R | Y | - | - | - | - | Shigella |
7 | R | Y | - | - | - | - | Shigella |
8 | R | Y | - | - | - | - | Shigella |
9 | R | Y | + | - | + | - | S. Typhi |
10 | R | Y | - | - | - | - | Shigella |
11 | R | Y | + | - | + | - | S. Typhi |
12 | R | Y | - | - | - | - | Shigella |
13 | R | Y | - | - | - | - | Shigella |
14 | R | Y | - | - | - | - | Shigella |
15 | R | Y | +2 | + | + | + | S. Typhimurium |
16 | R | Y | +2 | + | + | + | S. Typhimurium |
17 | R | Y | + | - | + | - | S. Typhi |
18 | R | Y | + | - | + | - | S. Typhi |
19 | R | Y | + | - | + | - | S. Typhi |
20 | R | Y | + | - | + | - | S. Typhi |
21 | R | Y | - | - | - | - | Shigella |
22 | R | Y | + | - | + | - | S. Typhi |
23 | R | Y | - | - | - | - | Shigella |
24 | R | Y | - | - | - | - | Shigella |
25 | R | Y | +2 | + | + | + | S. Typhimurium |
26 | R | Y | - | - | - | - | Shigella |
27 | R | Y | + | - | + | - | S. Typhi |
28 | R | Y | - | - | - | - | Shigella |
29 | R | Y | + | - | + | - | S. Typhi |
30 | R | Y | - | - | - | - | Shigella |
31 | R | Y | + | - | + | - | S. Typhi |
32 | R | Y | - | - | - | - | Shigella |
33 | R | Y | + | - | + | - | S. Typhi |
34 | R | Y | - | - | - | - | Shigella |
35 | R | Y | + | - | + | - | S. Typhi |
36 | R | Y | - | - | - | - | Shigella |
37 | R | Y | - | - | - | - | Shigella |
Key: R = Red slope; Y= Yellow butt; H2S = Hydrogen sulphide blackening; - = Negative; + = Positive
Figure 1: Percentage distribution of Salmonella and Shigella species
Figure 2: Distribution of the isolates based on gender
Figure 3: Age distribution of individuals positive for Salmonella and Shigella species
Plate 1: Tubes showing reaction of the isolates on Kligler iron agar
Table 2: Antibiotic susceptibility test of the isolates
Antibiotics | Organism isolated | |||||
---|---|---|---|---|---|---|
Salmonella Typhi n = 13 |
Salmonella Typhimurium n =3 |
Shigella spp. n = 21 |
||||
Susceptible | Resistant | Susceptible | Resistant | Susceptible | Resistant | |
Ampicillin 25µg | 0 (0.0%) | 13 (100%) | 1 (33.3%) | 2 (66.7%) | 1 (4.8%) | 20 (95.2%) |
Ceftriaxone 30µg | 10 (76.9%) | 3 (23.1%) | 1 (33.3%) | 2 (66.7%) | 14 (66.7%) | 7 (33.3%) |
Cephalexin 15µg | 3 (23.1%) | 10 (76.9%) | 1 (33.3%) | 2 (66.7%) | 4 (19%) | 17(81%) |
Chloramphenicol 30µg | 7 (53.8%) | 6 (46.2%) | 3 (100%) | 0 (0.0%) | 12 (57.1%) | 9 (42.9%) |
Ciprofloxacin 10µg | 7 (53.8%) | 6 (46.2%) | 3 (100%) | 0 (0.0%) | 18 (85.7%) | 3 (14.3%) |
Co-trimoxazole 25µg | 4 (30.8%) | 9 (69.2%) | 1 (33.3%) | 2 (66.7%) | 6 (28.6%) | 15 (71.4%) |
Gentamicin 10µg | 10 (76.9%) | 3 (23.1%) | 3 (100%) | 0 (0.0%) | 19 (90.5%) | 2 (9.5%) |
Nitrofurantoin 200µg | 7 (53.8%) | 6 (46.2%) | 3 (100%) | 0 (0.0%) | 11 (52.4%) | 10 (47.6%) |
Ofloxacin 10µg | 8 (61.5%) | 5 (38.5%) | 2 (66.7%) | 1 (33.3%) | 20 (95.2%) | 1 (4.8%) |
Tetracycline 25µg | 5 (38.5%) | 8 (61.5%) | 1 (33.3%) | 2 (66.7%) | 7 (33.3%) | 14 (66.7%) |
The Salmonella enterica Typhimurium isolates also displayed an overall susceptibility of 100% to Gentamicin, Ciprofloxacin, Chloramphenicol, and Nitrofurantoin. Shigella species showed an overall susceptibility of 95.2%, 90.5%, and 85.7% to Ofloxacin, Gentamicin, and Ciprofloxacin, respectively, while Salmonella enterica Typhi isolates exhibited an overall susceptibility of 76.9% to Gentamicin and Ceftriaxone. These findings also agree with those of Assefa and Girma (2019) and Tosisa et al. (2020), who reported susceptibility of Salmonella and Shigella to Gentamicin and Ciprofloxacin.
Findings from this study therefore indicate a Salmonella and Shigella incidence rate of 47.4% within the study area, with these organisms developing complete resistance to Ampicillin, Cephalexin, Co-trimoxazole, and Tetracycline. However, Gentamicin and Ciprofloxacin have proven to be the drugs of choice for the treatment of infections caused by these pathogens. Thus, the availability of potable water supplies, embracing hygienic practices, and continuous assessment would help curb the spread of these organisms. More importantly, the populace should also take charge of the quality of their drinking water by embracing point-of-use (POU) treatment methods such as boiling and disinfection.
Abebe, W., Earsido, A., Taye, S., Assefa, M., Eyasu, A. and Godebo, G. (2018). Prevalence and antibiotic susceptibility patterns of Shigella and Salmonella among children aged below five years with Diarrhoea attending Nigist Eleni Mohammed memorial hospital, South Ethiopia. BMC Pediatrics 18:241. [Crossref]
Adekunle, O.T., Olapade, B.O., Olaniran, O., Hassan-Olajokun, R.E., Afolayan, D.O., Shittu, O.B. and Awoyeni, A.E. (2015). Prevalence and antimicrobial susceptibility patterns of Salmonella and Shigella in HIV patients in Ile-Ife, Osun State. International Journal of Biomedical and Advance Research 6(05): 413-417.
Agbabiaka, T.O., Shitu, T., Agbabiaka, T.O. and Otuyelu, F. O. (2021). Biofilm-forming bacteria and their antibiotic resistance in treated water supplies in Ilorin Metropolis, Nigeria. Ceylon Journal of Science 50(2): 199-204. [Crossref]
Assefa, A. and Girma, M. (2019). Prevalence and antimicrobial susceptibility patterns of Salmonella and Shigella isolates among children aged below five years with diarrhea attending Robe General Hospital and Goba Referral Hospital, South East Ethiopia. Tropical Diseases, Travel Medicine and Vaccines 5(19): 1-11. [Crossref]
Chessebrough, M. (2006). District Laboratory Practice in Tropical Countries 2nd edn (2) Cambridge University Press UK 182-187.
CLSI (2016). Performance Standards for Antimicrobial Susceptibility Testing. 26th Edition, Clinical and Laboratory Standards Institute supplement M100S.
Dessale, M., Mengistu, G. and Mengist, H.M. (2023) Prevalence, antimicrobial resistance pattern, and associated factors of Salmonella and Shigella among under five diarrheic children attending public health facilities in Debre Markos town, Northwest Ethiopia. Frontiers in Public Health 11:1114223 1 -15. [Crossref]
Diriba, K., Awulachew, E. and Ashuro, Z. (2020). Prevalence and Antimicrobial Resistance Pattern of Salmonella, Shigella, and Intestinal Parasites and Associated Factor among Food Handlers in Dilla University Student Cafeteria, Dilla, Ethiopia. International Journal of Microbiology 20: 1-10. [Crossref]
Legese, H., Kahsay, T., Gebrewahd, A., Berhe, B., Fseha, B., Tadesse, S., Gebremariam, G., Negash, H., Mardu, F., Tesfay, K. and Adhanom, G. (2020). Prevalence, antimicrobial susceptibility pattern, and associated factors of Salmonella and Shigella among food handlers in Adigrat University student’s cafeteria, northern Ethiopia, Tropical Diseases, Travel Medicine and Vaccines 6(19): 1-9. [Crossref]
Nadeem, S.F., Gohar, U.F., Tahir, S.F., Mukhtar, H., Pornpukdeewattana, S., Nukthamna, P., Moula, A.M., Ali, S.C.B. Bavisetty, S. M. (2020). Antimicrobial resistance: more than 70 years of war between humans and bacteria. Crit. Rev. Microbiol., 46 pp. 578-599. [Crossref]
Ovia, K., Ibiam, U., Okoh, N., Okafor, C., Eromonsele, B., Okoroafor, I. and Ejikeugwu, C. (2023). Antibiogram of clinical isolates of Escherichia coli and Klebsiella species producing extended spectrum beta lactamase (ESBL). Nigerian Journal of Microbiology, 37(1): 6442 – 6450.
Tesfahun, L., Tsige, K. and Ketema, B. (2016). Prevalence and antimicrobial resistance in Salmonella and Shigella Species isolated from outpatients, Jimma University Specialized Hospital, Southwest Ethiopia. Canadian Journal of Infectious Diseases and Medical Microbiology, 16: 1-8. [Crossref]
Tosisa, W., Mihret, A., Ararsa, A., Eguale, T. and Abebe, T. (2020). Prevalence and antimicrobial susceptibility of Salmonella and Shigella species isolated from diarrheic children in Ambo town. BMC Pediatrics 20:91. [Crossref]
World Health Organization. WHO. (2003). World Health Organization Bulletin, Drug Resistance Salmonella and Shigella; Available. http/www.int/Media centre/factsheet/. Accessed March 20, 2009.
World Health Organization. WHO. Diarrhoeal Disease. Geneva: World Health Organization (2017). Available online at: https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease (accessed February 23, 2022)